• Disease Team Leader - Lung Cancer and Thoracic Scientific Team, UH Cleveland Medical Center
  • Professor, Medicine, CWRU School of Medicine
  • Lucile and Robert H Gries Endowed Director, Center for Cancer Drug Development, University Hospitals
  • Director, Thoracic Oncology Program, UH Seidman Cancer Center


  • Gender: Male
  • Online Personal Health Record Available

Board Certifications

American Board of Internal Medicine - Internal Medicine
American Board of Internal Medicine - Medical Oncology

Education & Training

Medical / Professional School(s)

1992, Universite de Liege Faculte de Medecine


1996, Internal Medicine - Universite de Liege Faculte de Medecine


2000, Internal Medicine - University Hospitals of Cleveland


1998, Hematology/Oncology - University Hospitals of Cleveland


Thoracic Cancer, Lung Cancer, Phase I Clinical Trials, Experimental Therapeutics, Hematology/Oncology

Office Locations

UH Cleveland Medical Center
Department of Medicine-Hematology and Oncology
11100 Euclid Ave
Cleveland, OH 44106
Get Directions

Patient Satisfaction Reviews

4.9 out of 5
41 Patient Satisfaction Ratings

About Our Survey

At University Hospitals, we believe in providing patients with all the information they need to make educated decisions about their health care and to choose the right doctor to meet their needs. That is why we partner with the independent patient satisfaction company Press Ganey to survey patients about their experiences at UH facilities and with UH physicians. We hold ourselves to the highest standards of care and are dedicated to creating a positive patient experience for every individual who sees a UH doctor.

Learn More

Patient Comments

Reviewed on 5/22/2017
Care provider very thorough, competent & knowledgeable.

Reviewed on 4/21/2017
This doc is amazing

Reviewed on 2/18/2017
Dr. Dowlati is a wonderful doctor.

Reviewed on 12/20/2016
doctor and staff had a very large patient load and did very well considering the work load they have to handle.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2015, Afshin Dowlati, MD did not disclose any Outside Relationships with Industry.

There is no publicly available rating for this medical professional because he or she either does not see patients or has not yet received the minimum number of Patient Satisfaction Reviews. To be eligible for display, we require a minimum of 30 surveys. This ensures that the rating is statistically reliable and a true reflection of patient satisfaction.

UH Quality Care Network, is a collaboration among independent and UH employed providers. The focus is on improving the quality and efficiency of care, as well as reducing the cost of care.